These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12836271)

  • 41. Biologically active antisense phosphorothioate oligodeoxyribonucleotides: synthesis, characterization, and studies of 3'-terminal phosphorothioate monoester analogues.
    Ravikumar VT; Lima WF; Van Sooy K; Turney B
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):149-60. PubMed ID: 15043143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rational selection of antisense oligonucleotide sequences.
    Smith L; Andersen KB; Hovgaard L; Jaroszewski JW
    Eur J Pharm Sci; 2000 Sep; 11(3):191-8. PubMed ID: 11042224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis of phosphorothioate oligonucleotide-peptide conjugates by solid phase fragment condensation.
    Diala I; Osada A; Maruoka S; Imanisi T; Murao S; Ato T; Ohba H; Fujii M
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6576-8. PubMed ID: 17942304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and binding properties of oligonucleotides carrying nuclear localization sequences.
    de La Torre BG; Albericio F; Saison-Behmoaras E; Bachi A; Eritja R
    Bioconjug Chem; 1999; 10(6):1005-12. PubMed ID: 10563769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced cellular binding of concatemeric oligonucleotide complexes.
    Simonova ON; Vladimirova AV; Zenkova MA; Vlassov VV
    Biochim Biophys Acta; 2006 Mar; 1758(3):413-8. PubMed ID: 16677598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Convenient synthesis of arabinonucleoside containing oligodeoxyribonucleotides.
    Ozaki H; Nakajima K; Izumi C; Sawai H
    Nucleic Acids Symp Ser; 2000; (44):37-8. PubMed ID: 12903256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oligonucleotides with 1,5-anhydrohexitol nucleoside building blocks: crystallization and preliminary X-ray studies of h(GTGTACAC).
    Declercq R; Van Aerschot A; Herdewijn P; Van Meervelt L
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):279-80. PubMed ID: 10089424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Application of antisense oligodeoxynucleotides for suppression of Na+/Ca2+ exchange.
    Schwaller B; Egger M; Lipp P; Niggli E
    Methods Enzymol; 2000; 314():454-76. PubMed ID: 10565032
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficient cleavage of RNA, enhanced cellular uptake, and controlled intracellular localization of conjugate DNAzymes.
    Kubo T; Takamori K; Kanno K; Bakalova R; Ohba H; Matsukisono M; Akebiyama Y; Fujii M
    Bioorg Med Chem Lett; 2005 Jan; 15(1):167-70. PubMed ID: 15582433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sequence preferences in cleavage of dsDNA and ssDNA by the extracellular Serratia marcescens endonuclease.
    Meiss G; Friedhoff P; Hahn M; Gimadutdinow O; Pingoud A
    Biochemistry; 1995 Sep; 34(37):11979-88. PubMed ID: 7547935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strand invasion by oligonucleotide--nuclease conjugates.
    Corey DR; Munoz-Medellin D; Huang A
    Bioconjug Chem; 1995; 6(1):93-100. PubMed ID: 7711111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, characterization and hybridization studies of an alternate nucleo-epsilon/gamma-peptide: complexes formation with natural nucleic acids.
    Roviello G; Musumeci D; Pedone C; Bucci EM
    Amino Acids; 2010 Jan; 38(1):103-11. PubMed ID: 19067107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of antisense oligonucleotide binding affinity to a structured RNA target.
    Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
    Biotechnol Bioeng; 1999 Oct; 65(1):1-9. PubMed ID: 10440665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation and characterization of antisense oligonucleotide-peptide hybrids containing viral fusion peptides.
    Soukchareun S; Tregear GW; Haralambidis J
    Bioconjug Chem; 1995; 6(1):43-53. PubMed ID: 7711103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oligonucleotide-poly-L-ornithine conjugates: binding to complementary DNA and RNA.
    Zhu T; Wei Z; Tung CH; Dickerhof WA; Breslauer KJ; Georgopoulos DE; Leibowitz MJ; Stein S
    Antisense Res Dev; 1993; 3(3):265-75. PubMed ID: 8286927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solid-phase synthesis, thermal denaturation studies, nuclease resistance, and cellular uptake of (oligodeoxyribonucleoside)methylborane phosphine-DNA chimeras.
    Krishna H; Caruthers MH
    J Am Chem Soc; 2011 Jun; 133(25):9844-54. PubMed ID: 21585202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Shifting RNA polymerase into overdrive.
    Landick R
    Science; 1999 Apr; 284(5414):598-9. PubMed ID: 10328742
    [No Abstract]   [Full Text] [Related]  

  • 58. Antisense technologies. Improvement through novel chemical modifications.
    Kurreck J
    Eur J Biochem; 2003 Apr; 270(8):1628-44. PubMed ID: 12694176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides.
    Andreola ML; Calmels C; Michel J; Toulmé JJ; Litvak S
    Eur J Biochem; 2000 Aug; 267(16):5032-40. PubMed ID: 10931185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inactivation of gene expression using ribonuclease P and external guide sequences.
    Guerrier-Takada C; Altman S
    Methods Enzymol; 2000; 313():442-56. PubMed ID: 10595372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.